Literature DB >> 8532700

Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.

M Krishna1, B Woda, L Savas, S Baker, B Banner.   

Abstract

Physiologic overexpression of p53 protein may occur in the G1 stage of the cell cycle to slow down the cell cycle and allow DNA repair in stressed or injured cells. We questioned whether there is increased expression of p53 protein in acutely inflamed mucosa (AI) and regenerated mucosa (RM) in ulcerative colitis (UC) and Crohn's disease (CD). Formalin-fixed paraffin-embedded sections of resected bowels from eight patients with UC and 20 with CD were reviewed, and blocks were selected having areas defined as follows: AI = two high-power fields (HPFs) at the edge of an ulcer, or one HPF with an inflamed crypt in the center; RM = branched or irregular glands with only mild chronic inflammation. Blocks with normal mucosa were available in 20 cases. One case of CD also had dysplasia, adenoma, and invasive carcinoma. p53 was identified with PAb1801 antibody using a labeled avidin-biotin immunoperoxidase technique. In each defined area, the positive nuclei were counted and expressed as the number of positive nuclei per 10 HPFs. Data were analyzed statistically for comparisons within and between the diseases. In normal mucosa, only rare cells expressed p53 in two cases of CD. The mean frequency of positive nuclei was 2.24/10 HPFs in AI and 0.30/10 HPFs in RM in CD, and 7.63/10 HPFs in AI and 1.14/10 HPFs in RM in UC. Differences between the means for AI and RM were statistically significant in both UC and CD. Although not significant, the frequency of positive staining in both AI and RM was greater in UC as compared with CD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532700

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

1.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage.

Authors:  D Guinee; M Fleming; T Hayashi; M Woodward; J Zhang; J Walls; M Koss; V Ferrans; W Travis
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.

Authors:  Joel R Pekow; Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Masha Kocherginsky; David T Rubin; Stephen B Hanauer; John Hart; Eugene B Chang; Alessandro Fichera; Loren J Joseph; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

4.  Bax is downregulated in inflamed colonic mucosa of ulcerative colitis.

Authors:  M Iimura; T Nakamura; S Shinozaki; B Iizuka; Y Inoue; S Suzuki; N Hayashi
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

5.  Expression of apoptosis-related proteins in rat with induced colitis.

Authors:  Giuseppe D'Argenio; Maria Grazia Farrace; Vittorio Cosenza; Francesca De Ritis; Nicola Della Valle; Francesco Manguso; Mauro Piacentini
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

6.  A proinflammatory cytokine inhibits p53 tumor suppressor activity.

Authors:  J D Hudson; M A Shoaibi; R Maestro; A Carnero; G J Hannon; D H Beach
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

7.  p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis.

Authors:  Yuji Yamanishi; David L Boyle; Douglas R Green; Edward C Keystone; Alison Connor; Susan Zollman; Gary S Firestein
Journal:  Arthritis Res Ther       Date:  2004-10-29       Impact factor: 5.156

8.  Apoptosis and p53 expression in rat adjuvant arthritis.

Authors:  P P Tak; M S Klapwijk; S F Broersen; D A van de Geest ; M Overbeek; G S Firestein
Journal:  Arthritis Res       Date:  2000-03-01

9.  Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model.

Authors:  Maitham A Khajah; Kethireddy V Ananthalakshmi; Ivan Edafiogho
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

10.  Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis.

Authors:  H Takaku; Y Ajioka; H Watanabe; H Hashidate; S Yamada; J Yokoyama; S Kazama; T Suda; K Hatakeyama
Journal:  Jpn J Cancer Res       Date:  2001-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.